The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Endogenous, hyperactive Rac3 controls proliferation of breast cancer cells by a p21-activated kinase-dependent pathway
Open accessAbstract
Uncontrolled cell proliferation is a major feature of cancer. Experimental cellular models have implicated some members of the Rho GTPase family in this process. However, direct evidence for active Rho GTPases in tumors or cancer cell lines has never been provided. In this paper, we show that endogenous, hyperactive Rac3 is present in highly proliferative human breast cancer-derived cell lines and tumor tissues. Rac3 activity results from both its distinct subcellular localization at the membrane and altered regulatory factors affecting the guanine nucleotide state of Rac3. Associated with active Rac3 was deregulated, persistent kinase activity of two isoforms of the Rac effector p21-activated kinase (Pak) and of c-Jun N-terminal kinase (JNK). Introducing dominant-negative Rac3 and Pak1 fragments into a breast cancer cell line revealed that active Rac3 drives Pak and JNK kinase activities by two separate pathways. Only the Rac3–Pak pathway was critical for DNA synthesis, independently of JNK. These findings identify Rac3 as a consistently active Rho GTPase in human cancer cells and suggest an important role for Rac3 and Pak in tumor growth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation
Khosravi-Far, R., Solski, P. A., Clark, G. J., Kinch, M. S., & Der, C. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.11.6443 · Cited by 683
Roberts, A. W., Kim, C., Zhen, L., Lowe, J. B., Kapur, R., Petryniak, B., Spaetti, A., Pollock, J. D., Borneo, J. B., Bradford, G. B., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80019-9 · Cited by 556
Rho family proteins and Ras transformation: the RHOad less traveled gets congested
Zohn, I. M., Campbell, S. L., Khosravi-Far, R., Rossman, K. L., & Der, C. J. (1998) · Oncogene · doi:10.1038/sj.onc.1202181 · Cited by 352
Membrane Association and Targeting of Prenylated Ras-like GTPases
Seabra, M. C. (1998) · Cellular Signalling · doi:10.1016/s0898-6568(97)00120-4 · Cited by 261
Characterization of RAC3, a Novel Member of the Rho Family
Haataja, L., Groffen, J., & Heisterkamp, N. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.33.20384 · Cited by 243
Self-citation
Cited by
Sahai, E., & Marshall, C. J. (2002) · Nature Reviews Cancer · doi:10.1038/nrc725 · Cited by 1,261
Rho GTPases and cell migration
Ridley, A. J. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.15.2713 · Cited by 1,191
Rational design and characterization of a Rac GTPase-specific small molecule inhibitor
Gao, Y., Dickerson, J. B., Guo, F., Zheng, J., & Zheng, Y. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307512101 · Cited by 1,091
Biology of the p21-Activated Kinases
Bokoch, G. M. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161742 · Cited by 1,089
Targeting Mitochondrial Glutaminase Activity Inhibits Oncogenic Transformation
Wang, J.-B., Erickson, J. W., Fuji, R., Ramachandran, S., Gao, P., Dinavahi, R., Wilson, K. F., Ambrosio, A. L. B., Dias, S. M. G., Dang, C. V., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.08.009 · Cited by 821
Rho GTPases in cancer cell biology
Vega, F. M., & Ridley, A. J. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.04.039 · Cited by 779
Krendel, M., Zenke, F. T., & Bokoch, G. M. (2002) · Nature Cell Biology · doi:10.1038/ncb773 · Cited by 669
Toll-like receptor 2–mediated NF-κB activation requires a Rac1-dependent pathway
Arbibe, L., Mira, J.-P., Teusch, N., Kline, L., Guha, M., Mackman, N., Godowski, P. J., Ulevitch, R. J., & Knaus, U. G. (2000) · Nature Immunology · doi:10.1038/82797 · Cited by 664
Self-citationRac and Rho GTPases in cancer cell motility control
Parri, M., & Chiarugi, P. (2010) · Cell Communication and Signaling · doi:10.1186/1478-811x-8-23 · Cited by 639
Rho-family GTPases: it's not only Rac and Rho (and I like it)
Wennerberg, K., & Der, C. J. (2004) · Journal of Cell Science · doi:10.1242/jcs.01118 · Cited by 613
p21-activated kinases in cancer
Kumar, R., Gururaj, A. E., & Barnes, C. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1892 · Cited by 604
Fibronectin, integrins, and growth control
Danen, E. H. J., & Yamada, K. M. (2001) · Journal of Cellular Physiology · doi:10.1002/jcp.1137 · Cited by 456
Sahai, E. (2001) · The EMBO Journal · doi:10.1093/emboj/20.4.755 · Cited by 384
Rho GTPase function in tumorigenesis
Karlsson, R., Pedersen, E. D., Wang, Z., & Brakebusch, C. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.03.003 · Cited by 329
Rho signals to cell growth and apoptosis
Aznar, S., & Lacal, J. C. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00412-8 · Cited by 310
PAK and other Rho-associated kinases – effectors with surprisingly diverse mechanisms of regulation
ZHAO, Z.-S., & MANSER, E. (2005) · Biochemical Journal · doi:10.1042/bj20041638 · Cited by 293
Rho GTPases: functions and association with cancer
Ellenbroek, S. I. J., & Collard, J. G. (2007) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9119-1 · Cited by 289
Requirement for PAK4 in the Anchorage-independent Growth of Human Cancer Cell Lines
Callow, M. G., Clairvoyant, F., Zhu, S., Schryver, B., Whyte, D. B., Bischoff, J. R., Jallal, B., & Smeal, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105732200 · Cited by 288
Yang, Z., Rayala, S., Nguyen, D., Vadlamudi, R. K., Chen, S., & Kumar, R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3480 · Cited by 272
The role of Rho GTPases in disease development
Boettner, B., & Van Aelst, L. (2002) · Gene · doi:10.1016/s0378-1119(02)00426-2 · Cited by 229
Characterization of EHop-016, Novel Small Molecule Inhibitor of Rac GTPase
Montalvo-Ortiz, B. L., Castillo-Pichardo, L., Hernández, E., Humphries-Bickley, T., De La Mota-Peynado, A., Cubano, L. A., Vlaar, C. P., & Dharmawardhane, S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.334524 · Cited by 213
Roles of the Rac1 and Rac3 GTPases in human tumor cell invasion
Chan, A. Y., Coniglio, S. J., Chuang, Y.-Y., Michaelson, D., Knaus, U. G., Philips, M. R., & Symons, M. (2005) · Oncogene · doi:10.1038/sj.onc.1208909 · Cited by 202
Self-citationPai, S.-Y., Kim, C., & Williams, D. A. (2010) · Disease Markers · doi:10.1155/2010/380291 · Cited by 85
Altered Rho GTPase Signaling Pathways in Breast Cancer Cells
Burbelo, P., Wellstein, A., & Pestell, R. G. (2004) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000018422.02237.f9 · Cited by 82
Rac1 Inhibits Apoptosis in Human Lymphoma Cells by Stimulating Bad Phosphorylation on Ser-75
Zhang, B., Zhang, Y., & Shacter, E. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.14.6205-6214.2004 · Cited by 69
Rac GTPases as key regulators of p210-BCR-ABL-dependent leukemogenesis
Thomas, E. K., Cancelas, J. A., Zheng, Y., & Williams, D. A. (2008) · Leukemia · doi:10.1038/leu.2008.71 · Cited by 60
Rho GTPases and Regulation of Hematopoietic Stem Cell Localization
(2008) · Methods in Enzymology · doi:10.1016/s0076-6879(07)00427-2 · Cited by 54
Generation of rac3 Null Mutant Mice: Role of Rac3 in Bcr/Abl-Caused Lymphoblastic Leukemia
Cho, Y. J., Zhang, B., Kaartinen, V., Haataja, L., de Curtis, I., Groffen, J., & Heisterkamp, N. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.13.5777-5785.2005 · Cited by 50
Self-citationExpression of RAC2 in endothelial cells is required for the postnatal neovascular response
De, P., Peng, Q., Traktuevc, D. O., Li, W., Yoder, M. C., March, K. L., & Durden, D. L. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.10.003 · Cited by 25
Interplay of PKA and Rac: Fine-tuning of Rac localization and signaling
Bachmann, V. A., Bister, K., & Stefan, E. (2013) · Small GTPases · doi:10.4161/sgtp.27281 · Cited by 14
Metadata
- Authors
- Mira, J.-P., Benard, V., Groffen, J., Sanders, L. C., & Knaus, U. G.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2000-01-04
- Volume
- 97
- Issue
- 1
- Pages
- 185-189
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1969814333
- Cited by
- 239
- References
- 6
- FWCI
- 5.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.